Stephen K Frankel

Summary

Publications

  1. doi request reprint The pulmonary vasculitides
    Stephen K Frankel
    Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, Colorado, USA
    Am J Respir Crit Care Med 186:216-24. 2012
  2. doi request reprint The pulmonary vasculitides
    Stephen K Frankel
    National Jewish Health, Denver, CO 80206, USA
    Clin Chest Med 31:519-36. 2010
  3. doi request reprint Update in idiopathic pulmonary fibrosis
    Stephen K Frankel
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Denver, Colorado, USA
    Curr Opin Pulm Med 15:463-9. 2009
  4. ncbi request reprint Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease
    Aryeh Fischer
    Division of Rheumatology, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206
    Chest 131:988-92. 2007
  5. doi request reprint A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes
    Tristan J Huie
    University of Colorado Denver, Division of Pulmonary Sciences and Critical Care Medicine, Aurora, Colorado 80045, USA
    Respirology 15:909-17. 2010
  6. pmc Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease
    Aryeh Fischer
    Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado 80206, USA
    J Rheumatol 40:640-6. 2013
  7. pmc Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
    Aryeh Fischer
    National Jewish Health, Interstitial and Autoimmune Lung Disease Program, Denver, CO 80206, United States
    Respir Med 103:1719-24. 2009
  8. doi request reprint Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series
    Amy L Olson
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Ave, C272, Denver, CO 80262, USA
    Chest 134:844-50. 2008
  9. pmc Challenges in pulmonary fibrosis. 3: Cystic lung disease
    Gregory P Cosgrove
    National Jewish Medical and Research Center, 1400 Jackson Street, F107, Denver, Colorado 80206, USA
    Thorax 62:820-29. 2007
  10. pmc Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis
    Jeffrey J Swigris
    Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Medical and Research Center, Denver, CO 80206, USA
    Chest 136:841-8. 2009

Collaborators

Detail Information

Publications17

  1. doi request reprint The pulmonary vasculitides
    Stephen K Frankel
    Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, Anschutz Medical Campus, University of Colorado, Aurora, Colorado, USA
    Am J Respir Crit Care Med 186:216-24. 2012
    ..This concise clinical review addresses the diagnosis and management of the patient with pulmonary vasculitis and provides an up-to-date review of the state of the field...
  2. doi request reprint The pulmonary vasculitides
    Stephen K Frankel
    National Jewish Health, Denver, CO 80206, USA
    Clin Chest Med 31:519-36. 2010
    ....
  3. doi request reprint Update in idiopathic pulmonary fibrosis
    Stephen K Frankel
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Denver, Denver, Colorado, USA
    Curr Opin Pulm Med 15:463-9. 2009
    ..This review aims to highlight and place in context recent advances in and insights into the natural history, diagnosis, and management of idiopathic pulmonary fibrosis (IPF)...
  4. ncbi request reprint Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease
    Aryeh Fischer
    Division of Rheumatology, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206
    Chest 131:988-92. 2007
    ..To determine the prevalence and significance of pericardial abnormalities in systemic sclerosis (SSc)-related interstitial lung disease (ILD)...
  5. doi request reprint A detailed evaluation of acute respiratory decline in patients with fibrotic lung disease: aetiology and outcomes
    Tristan J Huie
    University of Colorado Denver, Division of Pulmonary Sciences and Critical Care Medicine, Aurora, Colorado 80045, USA
    Respirology 15:909-17. 2010
    ..A comprehensive diagnostic evaluation is recommended for all patients with fibrotic lung disease and acute respiratory decompensation. However, the effect on clinical outcomes of this evaluation remains unknown...
  6. pmc Mycophenolate mofetil improves lung function in connective tissue disease-associated interstitial lung disease
    Aryeh Fischer
    Autoimmune and Interstitial Lung Disease Program, National Jewish Health, Denver, Colorado 80206, USA
    J Rheumatol 40:640-6. 2013
    ..We examined the tolerability and longitudinal changes in pulmonary physiology in a large and diverse cohort of patients with CTD-ILD treated with MMF...
  7. pmc Anti-synthetase syndrome in ANA and anti-Jo-1 negative patients presenting with idiopathic interstitial pneumonia
    Aryeh Fischer
    National Jewish Health, Interstitial and Autoimmune Lung Disease Program, Denver, CO 80206, United States
    Respir Med 103:1719-24. 2009
    ..To describe the clinical features of patients presenting with "idiopathic" interstitial pneumonia that were diagnosed with anti-synthetase syndrome based on clinical features and positive anti-PL-7 or PL-12 antibodies...
  8. doi request reprint Acute exacerbations of fibrotic hypersensitivity pneumonitis: a case series
    Amy L Olson
    Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 East Ninth Ave, C272, Denver, CO 80262, USA
    Chest 134:844-50. 2008
    ..While best described in patients with IPF, they have also been reported in patients with other forms of interstitial lung disease. We sought to determine if this same phenomenon occurs in patients with hypersensitivity pneumonitis (HP)...
  9. pmc Challenges in pulmonary fibrosis. 3: Cystic lung disease
    Gregory P Cosgrove
    National Jewish Medical and Research Center, 1400 Jackson Street, F107, Denver, Colorado 80206, USA
    Thorax 62:820-29. 2007
    ....
  10. pmc Heart rate recovery after 6-min walk test predicts survival in patients with idiopathic pulmonary fibrosis
    Jeffrey J Swigris
    Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Medical and Research Center, Denver, CO 80206, USA
    Chest 136:841-8. 2009
    ....
  11. doi request reprint Increased cell surface Fas expression is necessary and sufficient to sensitize lung fibroblasts to Fas ligation-induced apoptosis: implications for fibroblast accumulation in idiopathic pulmonary fibrosis
    Murry W Wynes
    Program in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA
    J Immunol 187:527-37. 2011
    ..Our findings also suggest that approaches aimed at increasing Fas expression by lung fibroblasts and myofibroblasts may be therapeutically relevant in IPF...
  12. pmc Compartmentalized expression of c-FLIP in lung tissues of patients with idiopathic pulmonary fibrosis
    Seung Ick Cha
    Program in Cell Biology, Department of Pediatrics, National Jewish Health, Denver, CO 80206, USA
    Am J Respir Cell Mol Biol 42:140-8. 2010
    ....
  13. ncbi request reprint Mycophenolate mofetil is safe, well tolerated, and preserves lung function in patients with connective tissue disease-related interstitial lung disease
    Jeffrey J Swigris
    Autoimmune Kung Center, Interstitial Lung Disease Program, National Jewish Medical and Research Center, 1400 Jackson St, Molly Blank J229, Denver, CO 80206, USA
    Chest 130:30-6. 2006
    ..In this study, our objectives were to examine the safety and tolerability of mycophenolate mofetil (MMF) and to determine its impact on lung function in patients with CTD-ILD...
  14. doi request reprint Eosinophilic lung diseases
    Evans R Fernandez Perez
    Interstitial Lung Disease Program, Autoimmune Lung Center, National Jewish Health, Denver, CO 80206, USA
    Med Clin North Am 95:1163-87. 2011
    ..This review focuses on the clinical features, general diagnostic workup, and management of the eosinophilic lung diseases...
  15. doi request reprint Diagnosis and management of pulmonary vasculitis
    Zulma X Yunt
    National Jewish Health, Denver, CO 80206, USA
    Ther Adv Respir Dis 6:375-90. 2012
    ..From a clinical perspective these remain among the most challenging of diseases both in terms of diagnosis and treatment. This review will focus on diagnosis and management of ANCA-associated vasculitides...
  16. ncbi request reprint Update in the diagnosis and management of pulmonary vasculitis
    Stephen K Frankel
    Department of Medicine, National Jewish Medical and Research Center, 1400 Jackson St, Denver, CO 80206, USA
    Chest 129:452-65. 2006
    ..However, for the purpose of this review, we will focus on the ANCA-associated vasculitides...
  17. ncbi request reprint A rare presentation of ischemic pseudomembranous colitis due to Escherichia coli O157:H7
    Jessica B Kendrick
    Department of Medicine, University of Colorado Denver and Health Sciences Center, Denver, CO, USA
    Clin Infect Dis 45:217-9. 2007
    ..Herein, we report a sporadic case of ischemic E. coli Ol57:H7 pseudomembranous colitis in an adult that occurred during a national outbreak of E. coli Ol57:H7 in the United States...